Education and Training
Continuous Glucose Monitoring to Aid Weight Loss in Prediabetes
The primary objective of this study is to determine whether intermittent use of continuous glucose monitor will facilitate weight loss in individuals who are overweight/obese with prediabetes.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- device: CGM
- other: Dietitian
Eligibility
Inclusion Criteria:
- Overweight/obese (BMI 25-40 kg/m2)
- Prediabetes (fasting glucose 100-125 mg/dL and/or HbA1c 5.7-6.4%)
Exclusion Criteria:
- On glucose-lowering medications (e.g., metformin)
- On weight-loss medications
Ages Eligible for Study
18 Years - 99 Years
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Associate Professor
650-723-8284
Not Recruiting